Clinical Trials
3 trialsNCT04294641 2026-01-23
Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00321893 2016-01-25
Budesonide in Treating Patients With Lung Nodules at High Risk of Developing Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00005880 2008-07-24
Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia
National Cancer Institute (NCI)
Phase 2 Completed